Femasys FEMY
NASDAQ FEMY
$1.50 -0.06 (-3.85%)
At close: Oct 23, 2026 · 4:00 PM EDT

Femasys (FEMY) Amortization of Deferred Charges (2023 - 2025)

Updated

Analysis

Femasys (FEMY) Amortization of Deferred Charges (2023 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.13 Bn 229.16 Bn 4.88 Bn
2 Abbott Laboratories 180.31 Bn 150.74 Bn 7.27 Bn
3 Danaher 162.34 Bn 146.15 Bn 3.61 Bn
4 Intuitive Surgical 158.13 Bn 138.42 Bn 2.08 Bn
5 Medtronic 122.37 Bn 87.63 Bn 6.34 Bn
6 Stryker 117.89 Bn 104.00 Bn 4.50 Bn
7 Boston Scientific 67.15 Bn 61.92 Bn 3.85 Bn
8 Becton Dickinson 54.68 Bn 51.83 Bn 2.32 Bn
9 Edwards Lifesciences 51.43 Bn 35.44 Bn 1.35 Bn
10 Femasys 5.12 Mn -15.55 Mn 189,391.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 213,897.00
Sep 30, 2025 426,541.00
Jun 30, 2025 389,913.00
Mar 31, 2025 356,699.00
Dec 31, 2024 337,672.00
Sep 30, 2024 310,539.00
Jun 30, 2024 285,561.00
Mar 31, 2024 258,802.00
Dec 31, 2023 107,963.00
API Access

Femasys Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=FEMY&period=max&api_key=YOUR_API_KEY